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BAF (Brg/Brm-associated factors) complexes play
important roles in development and are linked to
chromatin plasticity at selected genomic loci.
Nevertheless, a full understanding of their role in
development and chromatin remodeling has been
hindered by the absence ofmutants completely lack-
ing BAF complexes. Here, we report that the loss
of BAF155/BAF170 in double-conditional knockout
(dcKO) mice eliminates all known BAF subunits, re-
sulting in an overall reduction in active chromatin
marks (H3K9Ac), a global increase in repressive
marks (H3K27me2/3), and downregulation of gene
expression. We demonstrate that BAF complexes
interact with H3K27 demethylases (JMJD3 and
UTX) and potentiate their activity. Importantly, BAF
complexes are indispensable for forebrain devel-
opment, including proliferation, differentiation, and
cell survival of neural progenitor cells. Our findings
reveal a molecular mechanism mediated by BAF
complexes that controls the global transcriptional
program and chromatin state in development.
INTRODUCTION
Chromatin remodeling is an important regulator of develop-
mental gene expression. Vertebrate mSWI/SNF, also known
as the Brg1/Brm-associated factor (BAF) complexes, contains
at least 15 different subunits, including two interchangeable
core ATPase subunits (Brg1 or Brm), invariant core (BAF47,
BAF155, and BAF170), and a variety of lineage-restricted sub-1842 Cell Reports 13, 1842–1854, December 1, 2015 ª2015 The Autunits (Ho and Crabtree, 2010). Together with core components,
Brg1 or Brm can remodel nucleosomes in vitro at a rate compa-
rable to that of the entire complex (Phelan et al., 1999). However,
hundreds of distinct BAF complexes are predicted to form in vivo
through combinatorial assembly (Ho and Crabtree, 2010). Inte-
grated BAF complex subunits, which interact through composite
surfaces with transcription factors, co-activators, co-repressors,
and signaling pathways, are essential for genome targeting and,
thus, are responsible for conferring functional specificity (Ho and
Crabtree, 2010; Narayanan and Tuoc, 2014).
Understanding the roles of BAF complexes in murine neural
development so far has been based on data from phenotypic
analyses of neural cell-type-specific mouse mutants of genes
encoding the ATPase subunit Brg1 and some other BAF subunits
(Bischof et al., 2015; Lessard et al., 2007; Matsumoto et al.,
2006; Ninkovic et al., 2013; Tuoc et al., 2013a; Vogel-Ciernia
et al., 2013; Weider et al., 2012; Wu et al., 2007; Yu et al.,
2013). In ATPase Brg1-deficient neural cells, other BAF subunits
are expressed at normal levels and are incorporated into ATPase
Brm-based complexes (Lessard et al., 2007). In addition, the loss
of both Brg1 and Brm subunits does not affect the expression of
other BAF subunits in cancer cell lines (Strobeck et al., 2002).
Because most BAF subunits have chromatin-, DNA-, and pro-
tein-binding capacity, BAF complexes lacking ATPase subunits
likely have additional ATPase-independent roles in development
(Chaiyachati et al., 2013). Thus, previous studies using knockout
mouse models of individual BAF subunits possibly did not pro-
vide a complete view of BAF complex function.
We previously demonstrated that a dynamic competition
between BAF155 and BAF170 subunits that determines the
mammalian body and cortical size takes place during embryo-
genesis and corticogenesis (Tuoc et al., 2013a, 2013b). Here
we present evidence that elimination of both core BAF155 and
BAF170 subunits causes proteasome-mediated degradation ofhors
Figure 1. The Expression of BAF155 and
BAF170 Is Indispensable for Telencephalon
Development
The telencephalon-specific dcKO_FoxG1-Cre
mutants lack the telencephalon at E16.5. Tel,
telencephalon; Di, diencephalon; Mes, mesen-
cephalon. Scale bar, 100 mm.the entire BAF complexes and impairs the global epigenetic and
gene expression program of forebrain development. We found
that BAF complexes themselves do not possess H3K27-methyl-
ating activity; however, they inhibit transcriptional repression in
neural cells by interacting with H3K27 demethylases and modu-
lating their activity.
RESULTS
Expression of BAF155 and BAF170 Is Required for
Forebrain Development
To examine the effects of loss of both BAF155 and BAF170 in
neural development, we crossed mice harboring floxed alleles
of BAF155 (Choi et al., 2012) and BAF170 (Tuoc et al., 2013a)
(BAF155fl/fl and BAF170fl/fl) with different Cre lines, including
tamoxifen (TAM)-inducible ubiquitous CAG-Cre (Hayashi and
McMahon, 2002), telencephalon-specific FoxG1-Cre (He´bert
and McConnell, 2000), cortical progenitor-specific Emx1-Cre
(Gorski et al., 2002), and projection neuron-specific Nex-Cre
(Goebbels et al., 2006), generating the corresponding dcKOmu-
tants dcKO_CAG-Cre, dcKO_FoxG1-Cre, dcKO_Emx1-Cre, and
dcKO_Nex-Cre. The dcKO_CAG-Cremutants died between em-
bryonic days 14.5 and 15.5 (E14.5–E15.5) with severe develop-
mental retardation upon TAM treatment at E10.5 (data not
shown). The telencephalon-specific dcKO_FoxG1-Cre embryos,
in which Cre was active from very early forebrain development
(E8.5) in the entire telencephalon, exhibited a complete loss of
the telencephalon structure (Figure 1, arrow), making these ani-
mals unsuitable for further study.
At E15.5, the cortex in dcKO_Emx1-Cre mutants was thinner
compared to that in the control brain, but still allowed the study
of important characteristics of corticogenesis in the absence of
both BAF155 and BAF170 (Figure 2; Figure S1). Double immuno-
labeling with Pax6, a marker of radial glial progenitors (RGs) in
the ventricular zone, and Tuj1, a marker for postmitotic neurons
in the cortical plate, revealed dramatically thinner proliferative
andmantle zones of the cortex in dcKO_Emx1-Cremutants (Fig-
ure 2A). The number of phosphorylated histone H3-positive
(pHH3+) dividing cortical progenitors in M phase was reduced
at E12.5, and these cells were almost absent at E15.5 in mutants
compared to controls (Figures 2B and 2C). To determinewhether
the loss of both BAF155 and BAF170 influenced differentiation
and cell-cycle progression of progenitors, we performed 24-hr
CIdU and 1-hr IdU pulse labeling of cycling cortical progenitor
cells in vivo. Triple-labeling immunohistochemistry (IHC) with
antibodies for CIdU, amarker for both exited and cycling progen-Cell Reports 13, 1842–1854, Ditors, IdU, an S phase progenitor marker,
and Ki67, a marker for proliferating pro-
genitors in all phases of the cell cycle(except late G2), revealed noCIdU+/Ki67/IdU progenitors ex-
iting from the cell cycle in the dcKO-Emx1-Cre cortex, whichwas
kept exclusively in S phase (Ki67+/CIdU+/IdU+) at E15.5 (Figures
2D and 2E; Figure S2A). We examined apoptosis in different
dcKO tissues and cultured cells by performing IHC and western
blot (WB) with cleaved Casp3 (Figure 2F; Figures S2B and S2C).
In cortex-specific dcKO_Emx1-Cre mutants, expression of
BAF155 and BAF170 was completely lost from E12.5. However,
a significant number of dead cells were found only after E14.5 in
Pax6+ cortical progenitors, but not in Tuj+ cortical neurons. Our
findings suggest the possibility that mutant progenitors, which
were exposed for a long period to a defective cell-cycle progres-
sion, undergo apoptosis. Accordingly, we detected no signifi-
cant number of dead cells in neuron-specific dcKO_Nex-Cre at
post-natal day 1 (P1) (Figure 2F) or cultured dcKO_CAG-Cre af-
ter 6 days of TAM treatment (data not shown).
To study cortical layer formation, we analyzed the expression
of neuronal layer-specific markers at E16.5. With the exception
of Rorb, expression of other indicated cortical layer markers
was largely lost in cortices of dcKO mutants (Figures 2G and
2H). Taken together, these findings indicate that expression of
BAF155 andBAF170 is vital for embryogenesis and forebrain for-
mation. During corticogenesis, loss of both BAF155 and BAF170
in RGs causes multiple defects in proliferation and differentiation
capacities of cortical progenitors and promotes cell death.
BAF155 and BAF170 Control the Stability of BAF
Complexes
Previous in vitro studies have shown that BAF155 and BAF170
directly interact with certain BAF subunits, including Brg1,
BAF60a, BAF57, and BAF47, to protect them from proteasome-
mediated degradation (Chen and Archer, 2005; Sohn et al.,
2007). However, our in vivo experiments indicated that, upon
loss of either BAF155 or BAF170 in the cortex of BAF155cKO_
Emx1-Cre and BAF170cKO_Emx1-Cre mice (Tuoc et al.,
2013a), the expression of other BAF subunits was largely pre-
served. This prompted us to investigate whether the expression
of both BAF155 and BAF170 subunits is required for the stability
of the known components of different BAF complexes. Strikingly,
we found that the expression of all tested BAF subunits was
reduced at E12.5 (Figure S3A) and largely absent at E16.5 (Fig-
ures 3A and 3B; Figures S3B–S3G) in cortical tissue of
dcKO_Emx1-Cre mutants. A similar effect was observed in WB
analyses of lysates of primary neurons from forebrains of E13.5
dcKO_CAG-Cre embryos (Figures S4A and S4B) and of embry-
onic stem cells (ESCs) from E3.5 dcKO_CAG-Cre blastocystsecember 1, 2015 ª2015 The Authors 1843
Figure 2. BAF155 and BAF170 Expression Is Essential for Cerebral Cortical Development
(A) Double IHC analyses using antibodies that specifically label RGs (Pax6) or neurons (Tuj1) at E15.5. Middle panels are higher magnification images of fields in
the cortex indicated by white frames.
(B and C) IHC (B) and quantitative analyses (C) showed the number of pHH3+ cortical progenitors in M phase in dcKO_Emx1-Cre mutants was diminished at
E12.5 and lost at E15.5.
(D and E) Experimental paradigm (D) for determining cell-cycle parameters and color scheme for immunolabeling of micrographs (in Figure S2A) are shown. (E)
Cell-cycle distribution of control and mutant CIdU-labeled cells determined by IHC (see also Figure S2A).
(F) (Right) Quantitative analyses showed that cortical tissues of mutants had a low number of Casp3+ apoptotic cells at P1 (dcKO-Nex_Cre) and E12.5–E13.5
(dcKO-Emx1_Cre) and a high number at E14.5–E16.5 (dcKO-Emx1_Cre), as determined by IHC (see also Figure S2B). (Left) Quantitative analyses revealed that
themajority of Casp3+ apoptotic cells were Pax6+ progenitors and cells with punctate forms (at the late phase of apoptosis) (see also Figure S2C for IHC images).
(G and H) IHC (G) and qRT-PCR (H) analyses of cortical phenotype at E16.5 with layer markers in an entire hemisphere (for Satb2 marker) and in a comparable
dorsal area (for Tbr1, Sox5, RORb, Cux1, and Reelin). Values are presented asmeans ± SEMs (n = 6; *p < 0.05, **p < 0.01, and ***p < 0.005). Cx, cortex; BG, basal
ganglion; L, layer. Scale bars, 100 mm.
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Figure 3. Expression of BAFSubunits at Pro-
tein Level Is Lost in dcKO Mutants
(A and B) Analysis of three core BAF subunits (Brg1,
Brm, and BAF47) in the dcKO_Emx1-Cre cortex at
E16.5 (see also Figure S3). (A) IHC of coronal sec-
tions is shown. (B) Quantification of fluorescence
signals in (A) is shown.
(C) Loss of Brg1 protein (IHC), but not Brg1 tran-
script (FISH), in dcKO_Emx1-Cre cortex at E16.5 is
shown (see also Figure S5).
(D) The qRT-PCR analysis of BAF subunit tran-
scripts in the cortex of dcKO_Emx1-Cre mutants.
Values are presented as means ± SEMs (n = 6; *p <
0.05, **p < 0.01, and ***p < 0.005; NS, not signifi-
cant). Cx, cortex; BG, basal ganglion. Scale bar,
100 mm.(Figure S4D) after treating with TAM for 4 days, which caused
efficient deletionof bothBAF155andBAF170within48hr.Collec-
tively, these results indicate that the loss of BAF155 and BAF170
in dcKOmutants eliminates all tested subunits of BAF complexes
in ESCs and cortical cells both in vitro and in vivo.
Interestingly, application of double fluorescence in situ hybrid-
ization and IHC (FISH/IHC) revealed that Brg1, BAF60a, and
BAF250a proteins were lost in cortical tissue of dcKO_Emx1-
Cre mutants, whereas their transcripts were largely preserved
(Figure 3C; Figure S5). Using qRT-PCR to compare the expres-
sion of BAF subunits at the transcript level in cortical tissue from
dcKO_Emx1-Cre embryos and dcKO_CAG-Cre primary neurons
and ESCs with corresponding controls, we similarly found that
the loss of both BAF155 and BAF170 did not affect the transcrip-
tion of most BAF subunits. Notably, only transcripts encoding
the unique neuron (n)BAF complex subunits, BAF53b, BAF45b,
and SS18l, were slightly downregulated in dcKO_Emx1-Cre
cortices (Figure3D).This ispossibly attributable toneuronaldiffer-
entiation defects, since no such difference at the transcript levelCell Reports 13, 1842–1854, Dwas found between dcKO_CAG-Cre and
control primary neurons (Figure S4E).
We then examined whether BAF sub-
units in dcKO mutants are degraded by
the ubiquitin-proteasome system (UPS),
focusing on two ATPase subunits, Brg1
and Brm. Protein ubiquitination (Ub) and
stability were analyzed in cultured pri-
mary neurons derived from E13.5 dcKO_
CAG-Cre embryo forebrain tissue using
different biochemical assays (Tuoc and
Stoykova, 2008b). First, we determined
whether Brg1 and Brm had undergone
ubiquitination in dcKO_CAG-Cre primary
neurons, which had been treated with
TAM for 24 hr, compared to the untreated
controls. Both proteins were immunopre-
cipitated from cell lysates with anti-Brg1
and anti-Brm antibodies, and the immu-
noprecipitates were analyzed for the
appearance of poly(Ub)-conjugated forms
of Brg1 and Brm (Figure 4A). In WBs ofimmunoprecipitates with an anti-polyubiquitin (Ub) antibody, a
large amount of ubiquitinated Brg1 and Brm proteins were de-
tected in TAM-treated cells (Figure 4A, smear bands), suggest-
ing that loss of BAF155 and BAF170 induces ubiquitination of
intracellular Brg1 and Brm proteins. Next we applied a pulse-
chase approach using the protein biosynthesis inhibitor cyclo-
heximide to compare the half-life of BAF subunits in TAM-treated
dcKO_CAG-Cre neurons (Figure 4B). In the absence of the pro-
teasome inhibitor MG132, 24-hr treatment with cycloheximide
led to a reduction in Brg1 and Brm protein levels. This loss of
Brg1 and Brm protein was substantially eliminated in the pres-
ence of MG132 (Figures 4B and 4C). Collectively, these results
indicated that Brg1 and Brm are degraded by the UPS in the
absence of BAF155 and BAF170.
Free subunits of multi-subunit complexes tend to be degraded
by protein quality control systems if not assembled into a
complex, a regulatory mechanism that serves to ensure proper
stoichiometry (Goldberg, 2003). We hypothesized that, in the
absence of BAF155/BAF170, BAF subunits dissociate from theecember 1, 2015 ª2015 The Authors 1845
Figure 4. BAF155 and BAF170 Are Required for the Integrity of BAF Complexes
(A) Ubiquitination assays were performed in dcKO_CAG-Cre primary neurons. WB analysis with an anti-polyubiquitin (Ub) antibody and with eluted proteins after
immunoprecipitation (IP) with Brg and Brm antibodies revealed a strong smeared band of ubiquitinated Brg1 and Brm in the absence of BAF155 and BAF170
(TAM+) compared with untreated controls (TAM). Blots (against anti-Brg1 and Brm antibodies) showed the inputs of corresponding IP experiments.
(B) Pulse-chase assay of protein stability in dcKO_CAG-Cre primary neurons using the protein synthesis inhibitor cycloheximide (CH) in the presence or absence
of the proteasome inhibitor MG132. A representative immunoblot is shown.
(C) Quantitative densitometry of immunoblots revealed proteasome-mediated degradation of Brg1 and Brm.
(D) Protein complex stability assay. Brg1 and Brm interactions with other BAF subunits in the presence (TAM) or absence (TAM+) of BAF155/BAF170 were
assessed by CoIP andWB analysis of MG132-treated dcKO_CAG-Cre primary neurons. Values are presented as means ± SEMs (n = 3; *p < 0.05, **p < 0.01, and
***p < 0.005).BAF complex prior to their degradation. To test this, we investi-
gated the interaction of BAF subunits with their core subunits
Brg1/Brm by performing co-immunoprecipitation (CoIP) ex-
periments with antibodies against both Brg1 and Brm using
MG132-treated dcKO_CAG-Cre neurons with and without
TAM administration (Figure 4D). We found that, under stringent
conditions in the presence of BAF155 and BAF170 (i.e., TAM),
all tested nBAF subunits physically associated with Brg1/Brm,
as previously reported (Lessard et al., 2007). In contrast, these
interactions were largely abolished in the absence of BAF155/
BAF170 (TAM+). Thus, BAF155 and BAF170 subunits are
required for the integrity of BAF complexes.
Global Impairment of Epigenetic and Gene Expression
Programs in dcKO Mutants
Previous reports have indicated that the loss or overexpression
of individual BAF subunits only influences local chromatin marks
without causing global effects (Ho et al., 2011; Singhal et al.,
2010; Tuoc et al., 2013a). The dcKO mutant mice generated
here allowed us to re-examine whether loss of the entire BAF
complexes has a global effect on epigenetics. To examine
repressive and active chromatin marks, we performed IHC on
cortical tissues from dcKO_Emx1-Cre mutants at E16.5 (Figures1846 Cell Reports 13, 1842–1854, December 1, 2015 ª2015 The Aut5A and 5B) and WB analyses of lysates of TAM-treated dcKO_
CAG-Cre primary neurons (Figure S4C) using antibodies against
H3K27me2, H3K27me3, and H3K9Ac. Strikingly, the loss of BAF
complexes resulted in a global reduction in active marks
(H3K9Ac) with a concurrent global increase in repressive marks
(H3K27me2 and H3K27me3) (Figures 5A and 5B; Figure S4C).
The increase in H3K27me3 over gene bodies in the murine
embryonic cortex resulting from the loss of BAF complexes
was confirmed by chromatin immunoprecipitation sequencing
(ChIP-seq) assays (Figures 5C–5E). The dcKO_Emx1-Cre em-
bryos manifested a clear overall increase in H3K27me3 levels
over gene bodies in E13.5 cortices (Figures 5C and 5E). The
trend also was clear in P1 cortices obtained from projection
neuron-specific dcKO_Nex-Cre mutants (Figure 5D). This dimin-
ished methylation appeared to be specific for H3K27, because
methylation on other lysines of H3, such as H3K4 and H3K9,
was not altered in the BAF155/BAF170-deficient cortex or pri-
mary neurons (Figures S6A and S6B). These findings suggest
that the presence of BAF complexes is essential for the balance
between global repressive and active epigenetic programs in
neural development.
Because H3K27me2/3 marks are chromatin modifications
associated with the repression of gene expression (Cao et al.,hors
Figure 5. BAF Complexes Control Global Epigenetic Programs in Cortical Development
(A and B) Global changes in active (H3K9Ac) and repressive (H3K27me2/3) chromatin marks in the dcKO_Emx1-Cre cortex. (A) IHC of coronal sections is shown.
(B) Quantification of fluorescence signals in (A) is shown.
(C and D) Genome-wide increases in H3K27me3 upon deletion of BAF complexes in E13.5 dcKO_Emx1-Cre (C) and P1 dcKO_Nex-Cre (D) cortices are shown, as
determined by ChIP-seq analysis of mutant and control chromatin (paired Student’s t test, p < 0.0001).
(E) Distribution of H3K27me3 along the bodies of representative genes that are important for cortical development in E13.5 control (red) and dcKO_Emx1-Cre
(blue) cortices. Depicted are distributions after IP (upper two rows) and in the inputs (bottom two rows). Values are presented as means ± SEMs (n = 6; ***p <
0.005). Cx, cortex; BG, basal ganglion; TSS, transcription start site; TES, transcription end site. Scale bar, 100 mm.2002; Pereira et al., 2010), the massive enhancement of
H3K27me2/3 in dcKO mutants would be expected to result in
marked downregulation of gene expression. To test this, we first
performed gene expression profiling of the dcKO null cortex
during the early stages of cortical neurogenesis (E12.5). This
analysis revealed that 1,723 transcripts were downregulated,
whereas only 102 transcripts were upregulated (Figures 6A–Cell Re6C; Table S1). Many of the downregulated genes are known to
play essential roles in brain development (Figures 6B and 6C;
Figure S6C; Table S2). We then compared the intersection
between the 1,723 genes downregulated following the deletion
of BAF complexes (Figure 6A) with previously reported data on
1,080 genes upregulated in the Ezh2cKO_Emx1-Cre cortex at
E12.5 in which H3K27me2/3 marks were removed (Pereiraports 13, 1842–1854, December 1, 2015 ª2015 The Authors 1847
Figure 6. Loss of BAF Complexes Results Predominantly in Downregulation of Gene Expression
(A) Cluster diagram shows statistically significant changes in gene expression in microarray analyses of three cortices of E12.5 dcKO_Emx1-Cre littermates.
(B and C) Validations of gene expression profile data by IHC (B) and qRT-PCR (C) are shown.
(D) Overlap between downregulated genes in microarray studies of E12.5 dcKO_Emx1-Cre embryos and upregulated genes in similar experiments on E12.5
Ezh2_Emx1-Cre embryos (Pereira et al., 2010) is shown.
(E) Comparison of average H3K27me3 tag density at loci of downregulated genes from gene expression profiling in (A), between control and dcKO_Emx1-Cre
cortices from E13.5 (paired Student’s t test p < 0.0001). Values are presented asmeans ±SEMs (n = 6; **p < 0.01 and ***p < 0.005). Cx, cortex; BG, basal ganglion;
TSS, transcription start site; TES, transcription end site. Scale bars, 100 mm.et al., 2010). Remarkably, BAF complexes positively regulated
the majority of genes repressed by the H3K27methyltransferase
Ezh2 (Figure 6D). In addition, genes that were downregulated in
the E12.5 cortex of dcKO_Emx1-Cre embryo showed an in-
crease in H3K27me3 levels (Figure 6E). These data suggest
that the regulation of H3K27me2/3 is crucial for normal gene
expression programs in cortical development.
BAF Complexes Modulate the Activity of H3K27
Demethylases
To investigate the mechanisms underlying BAF155/BAF170-
mediated global control over the epigenetic program during
neurogenesis, we asked whether BAF complexes interact
with chromatin-modifying enzymes and modulate their enzy-1848 Cell Reports 13, 1842–1854, December 1, 2015 ª2015 The Autmatic activity. To search for BAF155/BAF170-interacting pro-
teins, we performed CoIP on cell lysates from forebrain tissue
of E13.5 or E17.5 wild-type (WT) mice and cultured neural
stem cells (NSCs; NS-5 line) using anti-BAF155 and anti-
BAF170 antibodies, followed by mass spectrometry (MS). The
results indicated that BAF155/BAF170 subunits interact with
numerous key factors involved in neural development. Interest-
ingly, BAF155 and BAF170 bound to UTX/Kdm6a and JMJD3/
Kdm6b (Figure S7A), the only enzymes known to specifically
demethylate H3K27me2/3 (Agger et al., 2007; De Santa et al.,
2007; Hong et al., 2007; Jepsen et al., 2007; Lan et al., 2007;
Lee et al., 2007; Shpargel et al., 2014; Xiang et al., 2007).
The interaction of BAF155 and BAF170 with these H3K27
demethylases was confirmed by WB analysis of BAF155 andhors
Figure 7. BAF Complexes Potentiate the H3K27 Demethylase Activity of UTX/Kdm6a and JMJD3/Kdm6b
(A) Interactions of BAF155 and BAF170 with UTX/Kdm6a and JMJD3/Kdm6bwere found in CoIP/MS (see in Figure S7A) and confirmed by CoIP andWB analysis
within E15.5 forebrain tissues.
(B) (Left) Binding of amixture of purified Flag-tagged BAF155 and BAF170 protein to a Kdm6b/JMJD3 peptide array is shown. (Right) Peptides bound by BAF155/
BAF170 are shown. Peptides numbered 462 and 463 are found in the conserved catalytic JmjC domain of the H3K27 demethylases UTX/Kdm6a and JMJD3/
Kdm6b (see also Figure S7B).
(C) A pull-down experiment was performed with purified HA-JMJD3 and Flag-BAF170 protein, which was pre-incubated with the synthesized peptides 462–643.
Note that the presence of the peptides substantially blocked interaction between BAF170 and JMJD3.
(legend continued on next page)
Cell Reports 13, 1842–1854, December 1, 2015 ª2015 The Authors 1849
BAF170 immunoprecipitates of lysates from E15.5 cortical tis-
sue (Figure 7A). Remarkably, CoIP/MS revealed that BAF155
and BAF170 bound to peptides within the JmjC domain, which
is required for the H3K27me2/3 demethylase activity of UTX/
Kdm6a and JMJD3/Kdm6b (Lan et al., 2007; Tsukada et al.,
2006; Xiang et al., 2007). To validate the BAF155/BAF170-bind-
ing domains of JMJD3/Kdm6b, we applied a purified Flag-
tagged BAF155 and BAF170 mixture to an array of JMJD3/
Kdm6b peptides. The results confirmed that the BAF155/
BAF170-binding domains lie within the conserved JmjC domain
of both UTX/Kdm6a and JMJD3/Kdm6b (Figure 7B; Figure S7B,
peptides 462–643). In addition, the specific interaction be-
tween BAF170 with JMJD3 via the JmjC domain was further
confirmed by pre-incubation with purified BAF170 and the syn-
thesized peptides 462–643 in the pull-down assay, as it was
largely blocked (Figure 7C). Furthermore, IHC analyses re-
vealed that BAF155 and BAF170 are co-expressed with UTX/
Kdm6a and JMJD3/Kdm6b throughout the entire developing
forebrain (Figure S7C).
Because the only enzymes known to methylate and demeth-
ylate H3K27 are Ezh1 and Ezh2 (or PRC2) (Cao et al., 2002; Per-
eira et al., 2010; Shen et al., 2008) and UTX/Kdm6a/JMJD3/
Kdm6b (Agger et al., 2007; De Santa et al., 2007; Hong et al.,
2007; Jepsen et al., 2007; Lan et al., 2007; Lee et al., 2007;
Xiang et al., 2007), respectively, we examined the possibility
that the increased level of H3K27me2/3 was attributable to
altered expression of these enzymes in dcKO mutants. How-
ever, this proved not to be the case, as deletion of BAF155
and BAF170 in dcKO_Emx1-Cre cortices and dcKO_CAG-Cre
primary neurons did not affect the level of these enzymes (Fig-
ures S6A and S6B). This suggests that BAF complexes control
the methylation of H3K27 through mechanisms other than
direct modulation of H3K27 demethylase and methyltransferase
expression.
These findings prompted us to investigate the effects of
endogenous BAF155 and BAF170 levels on the demethylase ac-
tivity of UTX/Kdm6a and JMJD3/Kdm6b. Cultured dcKO_CAG-
Cre neurons were nucleofected with mammalian expression
vectors for either UTX/Kdm6a-IRES-GFP or JMJD3/Kdm6b-
IRES-GFP in the presence of TAM (loss of both BAF155 and
BAF170) or absence of TAM (control) (Figure 7D). After 2 days
in vitro (2 DIV), GFP-positive (GFP+) cells were enriched by fluo-
rescence-activated cell sorting (FACS) and analyzed for UTX/
Kdm6a and JMJD3/Kdm6b demethylase activity by WB with
antibodies against H3K27me2 and H3K27me3. Notably, we
found that the H3K27 demethylase activities of both UTX/
Kdm6a and JMJD3/Kdm6b were lower in neurons lacking
BAF155 and BAF170 (TAM+) than in control (TAM) neurons
(Figure 7D, lanes 3 and 5). We then examined whether the BAF(D–F) Requirement of BAF complexes for the full H3K27 demethylase activity of
demethylase assays. WB with a GFP antibody indicated that an equal amount o
between BAF155/BAF170 and the demethylases by peptides 462–643 diminishe
(G and H) BAF complexes control the accessibility of JMJD3/UTX to H3, as reve
(I) The qRT-PCR analyses of dcKO_Emx1-Cremutants at E16.5 show the effects o
the expression of BAF complex target genes.
(J) A hypothetical model proposing how loss of BAF155 and BAF170 in dcKOmuta
expression program. Values are presented as means ± SEMs (n = 6; *p < 0.05, *
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Kdm6a and JMJD3/Kdm6b. In vitro histone demethylase assays
using purified H3 and UTX/Kdm6a/JMJD3/Kdm6b proteins and
reconstituted BAF complexes (recBAFs) (Phelan et al., 1999)
containing five core subunits (Brg1, Brm, BAF155, BAF170,
and BAF47) revealed that recBAFs dramatically increased the
enzymatic activity of both UTX/Kdm6a and JMJD3/Kdm6b
(Figure 7E, lanes 3, 6, and 9). Furthermore, the blockage of inter-
action between BAF155/BAF170 and JMJD3/UTX by the syn-
thesized peptides 462–643 reduced H3K27me2/3 demethyla-
tion (Figure 7F, lane 4).
To understand a biochemical basis for the ability of BAF com-
plexes to enhance H3K27 demethylase activity, we examined
the accessibility of JMJD3, UTX, and EZH2 to H3 in the absence
and presence of BAF complexes by performing a CoIP with an
antibody against H3, using dcKO_CAG-Cre neurons with and
without TAM administration (Figure 7G). We found that the
absence of BAF155/BAF170 (TAM+) did not affect the interac-
tion between H3 and EZH2, whereas the interactions between
H3 and JMJD3/UTX were largely abolished. In addition, an H3
pull-down assay using purified H3, UTX, JMJD3, proteins, and
recBAFs revealed that recBAFs substantially increased the bind-
ing between H3 and JMJD3/UTX (Figure 7H). Thus, our findings
implicated that BAF complexes modulate H3K27 demethylase
activity of JMJD3/UTX by regulating their accessibility to H3.
To determine more directly whether H3K27me2/3-dependent
epigenetic regulation influences BAF complex-dependent gene
expression, we used GSK126, an H3K27me2/3 methyltransfer-
ase EZH2 inhibitor (McCabe et al., 2012). GSK126 administration
in dcKO_Emx1-Cre mutants at E11.5 and E12.5 significantly
enhanced the expression of six of 22 genes, as assessed by
qRT-PCR (Figure 7I). Taken together, these in vivo and in vitro
findings demonstrate that the presence of BAF complexes is
required for the full H3K27 demethylase activity of UTX/Kdm6a
and JMJD3/Kdm6b and is essential for the proper gene expres-
sion program.
Collectively, our results suggest that the scaffolding
subunits BAF155 and BAF170 are indispensable for fore-
brain development. More specifically, our data suggest that
BAF155/BAF170-dependent chromatin remodeling facilitates
global gene regulation through direct interactions of these
subunits with H3K27 demethylases that potentiate their ac-
tivity (Figure 7J).
DISCUSSION
We investigated the roles of the two paralogous subunits,
BAF155 and BAF170, in different cell types and demonstrated
that these two subunits are essential regulators of the stabilityUTX/Kdm6a and JMJD3/Kdm6b, demonstrated by in vivo (D) and in vitro (E)
f electroporated cells was used in the assay (D). The blockade of interaction
d H3K27me2/3 demethylation (F).
aled by CoIP (G) and pull-down (H) experiments.
f treatment with the H3K27me2/3methyltransferase EZH2 inhibitor GSK126 on
nts controls the stability of BAF complexes and the epigenetic and neural gene
*p < 0.01, and ***p < 0.005). Ac, H3K9Ac; Me, H3K27me2/3; Ub, ubiquitin.
hors
and activity of BAF complexes. We showed that expression
of BAF155 and BAF170 is critical for formation of the fore-
brain and cortex. Our data indicated that BAF155 and
BAF170 subunits have an essential function in controlling
global H3K27me2/3 levels and gene expression program
by modulating the enzymatic activity of Kdm6a (UTX) and
Kdm6b (JMJD3) toward histone 3.
BAF155 and BAF170 Control the Stability and Function
of the BAF Complexes
The data presented here highlight the role of BAF155 and
BAF170 subunits as essential regulators of BAF complex func-
tion(s). BAF155 is highly expressed in proliferating stem/pro-
genitor cells in different tissues and cell lineages, whereas its
expression generally is downregulated during differentiation
(Ho et al., 2009; Tuoc et al., 2013a; Yan et al., 2008). In contrast,
BAF170 is expressed at lower levels in stem/progenitor cells and
at higher levels in differentiated cells (Ho et al., 2009; Tuoc et al.,
2013a; Yan et al., 2008). Nevertheless, our data indicate that low
levels of BAF155 and BAF170 in post-mitotic cells and dividing
stem/progenitor cells, respectively, are required to maintain
the stability of all distinct BAF complexes in cortex (Figure 3; Fig-
ures S3–S5), including npBAF (Lessard et al., 2007), nBAF (Wu
et al., 2007), BAF-A, BAF-B, and PBAF (Yan et al., 2008).
Previous studies have shown that ESCs, which contain
distinctive esBAF complexes, express high levels of Brg1 and
BAF155, but only low levels of Brm and BAF170 (Yan et al.,
2008) or virtually none at all (Ho et al., 2009). However, a recent
study reported that Brm catalyzes a minor fraction of esBAF
complexes (Smith-Roe and Bultman, 2013), challenging the
idea that Brg1 is the exclusive catalytic subunit of BAF com-
plexes in ESCs. Although outside the focus of our study, we
hypothesized that a low level of BAF170 expression together
with BAF155 is required for the stability of the esBAF complex,
as in late cortical progenitors (Figure 3A; Figure S3; Tuoc et al.,
2013a). Therefore, we derived a dcKO_CAG-Cre ESC line from
the corresponding transgenic blastocysts and examined pro-
tein levels of BAF subunits. We found that expression of all
BAF subunits examined was almost completely abrogated in
dcKO_CAG-Cre ESCs after 4 days of TAM treatment, as repre-
sented by Brg1 and Brm (Figure S4D). Taken together with our
other findings, these results indicate that the loss of BAF155/
BAF170 in dcKO mutants eliminates all known subunits of
BAF complexes in cortical tissues, primary neurons, and
ESC. Thus, dcKO mutants can be powerful tools for investi-
gating the roles of the entire BAF complexes in development
in vivo and in vitro.
It was recently reported that BAF subunits dissociate from
each other in BAF250a/b double mutants, indicating that these
subunits are important for the formation of BAF complexes
(Helming et al., 2014). However, in contrast to our BAF155/
BAF170-dcKO mutant, expression of many BAF subunits was
only modestly reduced or even preserved in BAF250a/b double
mutants. Similar to the case for other BAF subunits, expression
of both BAF250a and BAF250b was lost in BAF155/BAF170-
dcKO mutants, suggesting the possibility that BAF155 and
BAF170 control the integrity of BAF complexes, at least in part,
by regulating BAF250a/b expression. Still, why all BAF subunitsCell Rebecame undetectable at the protein level in BAF155/BAF170-
dcKO mutants, but not in BAF250a/b double mutants, re-
quires further investigation. Interestingly, among BAF155- and
BAF170-interacting proteins identified in our CoIP/MS analysis
were numerous factors belonging to the UPS, such as ubiquitin
ligases, deubiquitylases, and proteasome subunits. A separate,
ongoing study is aimed at investigating the possibility that, in
addition to their role in maintaining formation of BAF complexes,
BAF155 and BAF170might protect other BAF subunits by block-
ing their UPS-mediated proteolysis.
BAF Complexes Control Global Epigenetic and Gene
Expression Programs in Cerebral Cortical Development
Developmental genes are poised to rapidly induce transcription
and gene expression during neural development (Hirabayashi
and Gotoh, 2010; Mohn et al., 2008; Tuoc et al., 2014). This
poised state includes the simultaneous presenceof histonemod-
ifications associated with transcriptional activation, such as
H3K9Ac, and transcriptional repression, such as H3K27me2/3,
which are established by the EZH2 methyltransferase of the
polycomb repressive complex 2 (PRC2) and are removed by
Kdm6a/b demethylases. Given that H3K27me2/3 marks are
crucial for repression of many developmental genes in different
tissues, the addition and removal of H3K27me3 in a cohort of tis-
sue-specific genes are important steps in regulating proliferation
and differentiation (Agger et al., 2007; Akizu et al., 2010; Bern-
stein et al., 2006; Boyer et al., 2006; Burgold et al., 2012; Cao
et al., 2002; Estara´s et al., 2012; Hirabayashi et al., 2009; Jepsen
et al., 2007; Lee et al., 2006, 2012; Li et al., 2014; Miller et al.,
2010; Pan et al., 2007; Pereira et al., 2010; Pirouz et al., 2013;
Shpargel et al., 2014; Zhao et al., 2007). Accordingly, the loss
of function of H3K27 methyltransferase EZH2 removes the
H3K27me3 repressive mark in cortical progenitors, affecting
the homeostasis of self-renewal and differentiation in the
cerebral cortex (Pereira et al., 2010). Although a role for H3K27
demethylases in brain development is not known, the loss of
both JMJD3 and Utx demonstrated significantly increased
H3K27me3 levels with severe deficits of embryoid body (EB) dif-
ferentiation in the double-mutant ESCs (Shpargel et al., 2014).
Hence, the data implicated that H3K27me3 plays an important
role in proliferation, differentiation, and cell-cycle progression.
An antagonistic relationship between PRC2 (H3K27 methyl-
transferase) and BAF complexes in modulating the level of
H3K27me2/3 at target gene locations has been reported,
although this remains a matter of considerable debate (Ho
et al., 2011; Kia et al., 2008; Shao et al., 1999; Wilson et al.,
2010). Loss of BAF47 in fibroblasts and cancer cells leads to
elevated expression of the polycomb gene EZH2 (Wilson et al.,
2010), whereas deletion of Brg1 does not lead to upregulation
of the PRC2 components Ezh2 or Suz12 in ESCs (Ho et al.,
2011). Similar to the deletion of Brg1 in ESCs, the loss of both
BAF155 and BAF170 does not affect the expression level of
EZH2 or SUZ12 in cortical tissue or primary neurons (Figures
S6A and S6B).
The removal of H3K27me2/3 marks is important for the
robust induction of many cell-type-specific genes during
differentiation (Burgold et al., 2008; Hirabayashi et al., 2009;
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The interaction between H3K27 demethylases (JMJD3 and
UTX) and BAF subunits has been reported in Th1 cells (Miller
et al., 2010) and lung tissues (Li et al., 2014), as well as in
cardiac development (Lee et al., 2012). H3K27 demethylases
and BAF complexes often are recruited to tissue-specific en-
hancers by key transcription factors, such as T-bet in Th1 cells
(Miller et al., 2010); Nkx2.1 in lung development (Li et al.,
2014); and SRF, Nkx2.5, Tbx5, and GATA4 in cardiac cells
(Lee et al., 2012). These findings reveal a functional interaction
between H3K27 demethylases and BAF complexes during the
transition from poised to active chromatin that triggers tissue-
specific chromatin changes during the development of many
organs. Nevertheless, the loss of individual BAF subunits influ-
ences H3K27me2/3 levels only locally (Ho et al., 2011; Tuoc
et al., 2013a). To date, no alteration in the bulk levels of
H3K27me3 has been observed in BAF subunit mutants (Ho
et al., 2011; Tuoc et al., 2013a). We showed in this study
that BAF complexes themselves do not possess H3K27-meth-
ylating activity; however, they inhibit transcriptional repression
in neural cells by potentiating Kdm6-mediated demethylation
of H3K27me2/3.
To gain a genome-wide perspective on the role of BAF com-
plexes in cortical development, we performed a transcriptome
analysis of the dcKO cortex. These data suggest an important
interaction between H3K27 methyltransferase and BAF com-
plexes, as evidenced by the fact that 90% of genes regulated
by the H3K27me2/3 methyltransferase EZH2 are regulated by
BAF complexes. Notably, these data also offer insights into the
H3K27me2/3-independent roles of BAF complexes. Accord-
ingly, our CoIP/MS data revealed that, in addition to H3K27
demethylases, BAF155 and BAF170 associate with many
other factors, including signaling pathway, transcriptional, chro-
matin-remodeling, and epigenetic machineries. How the inter-
action between BAF complexes and these factors control gene
expression programs at distinct neural developmental stages
is an essential question that needs to be addressed in future
studies.
Distinct BAF complexes have been shown to bind to and co-
ordinate with tissue-specific transcription factors to regulate
gene expression in different cell types, which explains the wide-
spread role of BAF complexes in the development of numerous
organs (Ho and Crabtree, 2010; Narayanan and Tuoc, 2014).
Although BAF complexes per se have essential roles in develop-
ment, analyses of mouse transgenic models in which individual
subunits are deleted have yielded only a pinhole view of in vivo
BAF complex function. Our data indicate that the expression of
BAF155 and BAF170 is indispensable for embryogenesis and
formation of the forebrain. In cortical development, BAF com-
plexes are essential for proliferation, differentiation, cell-cycle
progression, cell survival, and layer formation.
In summary, we showed that the absence of BAF155 and
BAF170 in dcKO mutants leads to the dissociation of all other
BAF subunits from the complex. Subsequently, the free BAF
subunits are degraded by the UPS. Thus, the generation of
dcKO mutants provides a tool to investigate the roles of entire
BAF complexes in development. Loss of the entire BAF com-
plex exerts effects on global chromatin status and gene expres-
sion in neural cells. As a small part of complex molecular inter-1852 Cell Reports 13, 1842–1854, December 1, 2015 ª2015 The Autactions influenced by chromatin remodeling and epigenetic
machinery, we have shown here that BAF155 and BAF170
mediate the interaction between BAF complexes and H3K27de-
methylases, controlling the global level of H3K27me2/3 and
ultimately the gene expression program in cortical develop-
ment. Our findings have uncovered an epigenetic mechanism
that controls corticogenesis. Understanding functional interac-
tions between BAF complexes and other factors of epigenetic
machinery during development is a challenging task for future
study.
EXPERIMENTAL PROCEDURES
Transgenic Mice
Floxed BAF155 (Choi et al., 2012), floxed BAF170 (Tuoc et al., 2013a), FoxG1-
Cre (He´bert and McConnell, 2000), Emx1-Cre (Gorski et al., 2002), CAG-Cre
(Hayashi and McMahon, 2002), and Nex-Cre (Goebbels et al., 2006) mice
were maintained in a C57BL6/J background. Animals were handled in accor-
dance with the German Animal Protection Law.
Plasmids and Antibodies
A list of plasmids and antibodies with detailed descriptions is provided in the
Supplemental Experimental Procedures.
MS, Peptide Assay, CoIP, ChIP-Seq and Microarray Analysis, and
qPCR
Detailed descriptions are provided in the Supplemental Experimental
Procedures.
IHC, FISH, and Cell-Cycle Index
IHC and determination of cell-cycle index were performed as previously
described (Tuoc et al., 2009).
In Vitro and In Vivo Demethylase Assays, Complex and Protein
Stability Assay, TAM, and GSK126 Treatment
Detailed descriptions of other methods are provided in the Supplemental
Experimental Procedures.
Culture of Standard Cell Lines, Primary Neurons, and ESCs
Cell culture conditions as well as derivation of mouse ESCs were described
previously (Pirouz et al., 2013; Tuoc and Stoykova, 2008a, 2008b).
Image Acquisition and Statistical Analysis
All images were acquired with standard (Leica DM 6000) and confocal (Leica
TCS SP5) fluorescence microscopes. Images were further analyzed with
Adobe Photoshop. Statistical analyses were done using Student’s t test. All
graphs are plotted as mean ± SEM.
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